Researchers studied 851 adults hospitalized with acute coronary syndromes or acute decompensated heart failure at two tertiary care academic hospitals. A randomized group of patients received ...

A clinic visit, hospital admission, or transition in care often begins with medication reconciliation. Developed to provide safer, more coordinated, and better-quality care, medication reconciliation ...

Proper medication reconciliation can help prevent adverse drug events by identifying exactly what medications a patient was taking before coming to the hospital and confirming appropriate medication ...

Background: Hospital discharge is an interface of care when patients are at a high risk of medication discrepancies as they transition from hospital to home. These discrepancies are important, as they ...

Please provide your email address to receive an email when new articles are posted on . With the rise of hospitalists, in an inpatient setting, this process is often handled and overseen by hospital ...

Phase Ib Study of BI 836880 (VEGF/Ang2 nanobody) in Combination With Ezabenlimab (anti–PD-1 antibody) in Patients With Advanced or Metastatic Solid Tumors From December 2022 to January 2025, one MRT ...

The Agency for Healthcare Research and Quality provides a free, downloadable medications at transitions and clinical handoffs toolkit for medication reconciliation. Medication reconciliation is a ...

Home health agencies can significantly reduce clients’ risk of hospitalization with a focus on medication evaluation and reconciliation, according to a new study. The researchers examined medication ...

Guidance on Appropriately Notifying Patients and Other Physicians for Improved Medication Reconciliation: Q&A With Jeannie Pezone of West Park Surgery Center Jeannie Pezone, administrator at West Park ...

Headlines in consumer and professional media outlets alike have made one thing abundantly clear: Healthcare providers are tired. According to a study published by the Mayo Clinic, 62.8% of physicians ...

Phase Ib Study of BI 836880 (VEGF/Ang2 nanobody) in Combination With Ezabenlimab (anti–PD-1 antibody) in Patients With Advanced or Metastatic Solid Tumors Accurate medication reconciliation is ...